Proteasome Inhibitor MG132 Facilitates Antiviral Effects by Inhibiting TFEB Degradation and Activating Autophagy
- 1Hainan University , , ,
Abstract
The ubiquitin-proteasome system, which serves as one of the most common cellular degradation pathways, plays a critical role in maintaining proteostasis. Yet, the correlation between the ubiquitin-proteasome system and antiviral defense remains to be defined. In this work, pharmacological inhibition of proteasomes via treatment with MG132, which inhibited proteasome activity during viral infection, facilitated antiviral effects in vitro. Similar to MG132, another proteasome inhibitor, bortezomib, effectively inhibited proteasome activity and exhibited antiviral effects. Guided by these findings, further assays demonstrated that MG132 blocked viral adsorption and internalization, which partially contributed to the antiviral effects. Meanwhile, MG132 inhibited TFEB degradation and promoted dephosphorylation of TFEB at Ser211, resulting in autophagy, which was associated with antiviral effects. Taken together, a key discovery of our study is the critical role of the proteasome inhibitor MG132 in promoting antiviral activity, providing valuable insights for the development of more effective antiviral strategies based on the autophagy signaling pathway mediated by TFEB.
Related
- Mild heat treatment ameliorates PCOS by activating PI3K/Akt signaling and inhibiting granulosa cell apoptosis
- Targeting proteasome composition reprograms tumor-intrinsic inflammation through selective degradation of STAT1
- SGLT2i protects against myocardial I/R-induced coronary microvascular injury by inhibiting glycocalyx degradation
- A multi-subunit autophagic capture complex facilitates degradation of ER-stalled MHC class I in pancreatic cancer
- Patient-reported outcomes and skeletal symptoms in multiple myeloma stratified by proteasome inhibitor-based therapy: a prospective interdisciplinary cohort study.
BibTeX
@article{liu2026proteasome,
title = {{Proteasome Inhibitor MG132 Facilitates Antiviral Effects by Inhibiting TFEB Degradation and Activating Autophagy}},
author = {Naiyu Liu and Yingrui Wei and Shanshan Fu and Kaiyue Zuo and Xinjie Zhu},
journal = {ACS Omega},
year = {2026},
month = oct,
doi = {10.1021/acsomega.6c00932},
url = {https://pubs.acs.org/acsodf/article/doi/10.1021/acsomega.6c00932/5460405/Proteasome-Inhibitor-MG132-Facilitates-Antiviral},
note = {CC BY-NC-ND 4.0},
}
RIS
TY - JOUR
TI - Proteasome Inhibitor MG132 Facilitates Antiviral Effects by Inhibiting TFEB Degradation and Activating Autophagy
AU - Naiyu Liu
AU - Yingrui Wei
AU - Shanshan Fu
AU - Kaiyue Zuo
AU - Xinjie Zhu
PY - 2026
DA - 2026/10/28
JO - ACS Omega
DO - 10.1021/acsomega.6c00932
UR - https://pubs.acs.org/acsodf/article/doi/10.1021/acsomega.6c00932/5460405/Proteasome-Inhibitor-MG132-Facilitates-Antiviral
AB - The ubiquitin-proteasome system, which serves as one of the most common cellular degradation pathways, plays a critical role in maintaining proteostasis. Yet, the correlation between the ubiquitin-proteasome system and antiviral defense remains to be defined. In this work, pharmacological inhibition of proteasomes via treatment with MG132, which inhibited proteasome activity during viral infection, facilitated antiviral effects in vitro. Similar to MG132, another proteasome inhibitor, bortezomib, effectively inhibited proteasome activity and exhibited antiviral effects. Guided by these findings, further assays demonstrated that MG132 blocked viral adsorption and internalization, which partially contributed to the antiviral effects. Meanwhile, MG132 inhibited TFEB degradation and promoted dephosphorylation of TFEB at Ser211, resulting in autophagy, which was associated with antiviral effects. Taken together, a key discovery of our study is the critical role of the proteasome inhibitor MG132 in promoting antiviral activity, providing valuable insights for the development of more effective antiviral strategies based on the autophagy signaling pathway mediated by TFEB.
SN - 2470-1343
ER -